Another study using the HDAC6 inhibitors CAY10603 and ACY1215 found that the mitogen-activated protein kinase kinase 7 (MKK7)/JNK/c-Jun pathway was repressed by those inhibitors, suppressing the growth of GBM xenografts in mice [133]. The gene discussed is MAP2K7; the disease is glioblastoma.